Nanoparticle Drug Delivery Platform

The use of polymers and polymeric structures in the treatment, diagnosis, and monitoring of biological systems is continuing to increase in sophistication. Research exploring the use of nanoparticles for drug delivery applications has included the exploration and development of nanocolloids, liposomes, micelles, nanogels, polymer‐drug conjugates, and a variety of other polymeric nanoparticles that are composed of organic polymers with specific physical or chemical properties that make them relevant delivery vehicles. One of the current trends is the fabrication of tunable, mono‐dispersed, polymeric nanostructures to be used as nanoparticle drug delivery platforms. The PRINT technology used to fabricate monodisperse particles from a wide range of particle matrix materials including biocompatible poly(ethylene glycol) and bioabsorbable poly(d‐lactic acid) is described along with an abbreviated overview of other polymeric drug delivery platforms.

[1]  C. Alving,et al.  Delivery of lipids and liposomal proteins to the cytoplasm and Golgi of antigen-presenting cells. mangala.rao@na.amedd.army.mil. , 2000, Advanced drug delivery reviews.

[2]  Masanori Sugisaka,et al.  From molecular biology to nanotechnology and nanomedicine. , 2002, Bio Systems.

[3]  Francis C Szoka,et al.  Designing dendrimers for biological applications , 2005, Nature Biotechnology.

[4]  Yechezkel Barenholz,et al.  Liposome application: problems and prospects , 2001 .

[5]  P. Cresswell,et al.  Enhanced and prolonged cross‐presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles , 2006, Immunology.

[6]  Maruyama,et al.  Possibility of active targeting to tumor tissues with liposomes. , 1999, Advanced drug delivery reviews.

[7]  Joseph M DeSimone,et al.  Direct fabrication and harvesting of monodisperse, shape-specific nanobiomaterials. , 2005, Journal of the American Chemical Society.

[8]  Stephanie E. A. Gratton,et al.  Imparting size, shape, and composition control of materials for nanomedicine. , 2006, Chemical Society reviews.

[9]  R. Langer,et al.  Biomaterials in drug delivery and tissue engineering: one laboratory's experience. , 2000, Accounts of chemical research.

[10]  R. Duncan,et al.  Dendrimer-platinate: a novel approach to cancer chemotherapy. , 1999, Anti-cancer drugs.

[11]  Kazunori Kataoka,et al.  Block copolymer micelles as long-circulating drug vehicles , 1995 .

[12]  P. Couvreur,et al.  Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications. , 2000, International journal of antimicrobial agents.

[13]  R. Samulski,et al.  Polymeric nanogels produced via inverse microemulsion polymerization as potential gene and antisense delivery agents. , 2002, Journal of the American Chemical Society.

[14]  V. Torchilin.  Recent advances with liposomes as pharmaceutical carriers , 2005, Nature Reviews Drug Discovery.

[15]  K. Nguyen,et al.  Development of a Temperature‐Sensitive Composite Hydrogel for Drug Delivery Applications , 2006, Biotechnology progress.

[16]  V. Torchilin,et al.  Targeted polymeric micelles for delivery of poorly soluble drugs , 2004, Cellular and Molecular Life Sciences CMLS.

[17]  Theresa M. Allen,et al.  Pharmacokinetics of long-circulating liposomes , 1995 .

[18]  D. Papahadjopoulos,et al.  Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. , 1999, Pharmacological reviews.

[19]  J. E. Puig,et al.  Thermoresponsive nanostructured poly(N-isopropylacrylamide) hydrogels made via inverse microemulsion polymerization , 2006 .

[20]  C. Benz,et al.  Targeting of Drugs to Solid Tumors Using Anti-Her2 Immunoliposomes , 1998 .

[21]  Bob Sievers,et al.  Nanomedicine for respiratory diseases. , 2009, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[22]  Y. Park.  Tumor-Directed Targeting of Liposomes , 2002, Bioscience reports.

[23]  John Samuel,et al.  Poly(ethylene oxide)-block-poly(L-amino acid) micelles for drug delivery. , 2002, Advanced drug delivery reviews.

[24]  María J Vicent,et al.  Polymer conjugates: nanosized medicines for treating cancer. , 2006, Trends in biotechnology.

[25]  Mitsuru Hashida,et al.  Nonviral approaches satisfying various requirements for effective in vivo gene therapy. , 2002, Biological & pharmaceutical bulletin.

[26]  R. Langer,et al.  Poly(Ethylene Oxide)-Modified Poly(β-Amino Ester) Nanoparticles as a pH-Sensitive System for Tumor-Targeted Delivery of Hydrophobic Drugs: Part 2. In Vivo Distribution and Tumor Localization Studies , 2005, Pharmaceutical Research.

[27]  R. Duncan.  The dawning era of polymer therapeutics , 2003, Nature Reviews Drug Discovery.

[28]  V. Torchilin.  Polymer-coated long-circulating microparticulate pharmaceuticals. , 1998, Journal of microencapsulation.

[29]  G Gregoriadis,et al.  Engineering liposomes for drug delivery: progress and problems. , 1995, Trends in biotechnology.

[30]  P. Couvreur,et al.  Nanoparticles in cancer therapy and diagnosis. , 2002, Advanced drug delivery reviews.

[31]  H. Fessi,et al.  Polymeric nanoparticles for oral delivery of drugs and vaccines: a critical evaluation of in vivo studies. , 2005, Critical reviews in therapeutic drug carrier systems.

[32]  Praveen Elamanchili,et al.  Biodegradable Nanoparticle Mediated Antigen Delivery to Human Cord Blood Derived Dendritic Cells for Induction of Primary T Cell Responses , 2003, Journal of drug targeting.

[33]  E. K. Park,et al.  Folate-conjugated methoxy poly(ethylene glycol)/poly(epsilon-caprolactone) amphiphilic block copolymeric micelles for tumor-targeted drug delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.